Pseudomonas aeruginosa Exotoxin A Reduces Chemoresistance of Oral Squamous Carcinoma Cell via Inhibition of Heat Shock Proteins 70 (HSP70)

Oral squamous carcinoma (OSCC) cells exhibit resistance to chemotherapeutic agent-mediated apoptosis in the late stage of malignancy. Increased levels of heat shock proteins 70 (HSP70) in cancer cells are known to confer resistance to apoptosis. Since recent advances in the understanding of bacteria...

Full description

Saved in:
Bibliographic Details
Published inYonsei medical journal Vol. 51; no. 5; pp. 708 - 716
Main Authors Park, Sang Rye, Lee, Kyoung Duk, Kim, Uk Kyu, Gil, Young Gi, Oh, Kyu Seon, Park, Bong Soo, Kim, Gyoo Cheon
Format Journal Article
LanguageEnglish
Published Korea (South) Yonsei University College of Medicine 01.09.2010
연세대학교의과대학
Subjects
Online AccessGet full text
ISSN0513-5796
1976-2437
1976-2437
DOI10.3349/ymj.2010.51.5.708

Cover

Abstract Oral squamous carcinoma (OSCC) cells exhibit resistance to chemotherapeutic agent-mediated apoptosis in the late stage of malignancy. Increased levels of heat shock proteins 70 (HSP70) in cancer cells are known to confer resistance to apoptosis. Since recent advances in the understanding of bacterial toxins have produced new strategies for the treatment of cancers, we investigated the effect of Pseudomonas aeruginosa exotoxin A (PEA) on HSP70 expression and induction of apoptosis in chemoresistant OSCC cell line (YD-9). The apoptotic effect of PEA on chemoresistant YD-9 cells was confirmed by MTT, Hoechst and TUNEL stains, DNA electrophoresis, and Western blot analysis. While YD-9 cells showed high resistance to chemotherapeutic agents such as etoposide and 5-fluorouraci (5-FU), HSP70 antisense oligonucelotides sensitized chemoresistant YD-9 cells to etoposide and 5-FU. On the other hand, PEA significantly decreased the viability of YD-9 cells by deteriorating the HSP70-relating protecting system through inhibition of HSP70 expression and inducing apoptosis in YD-9 cells. Apoptotic manifestations were evidenced by changes in nuclear morphology, generation of DNA fragmentation, and activation of caspases. While p53, p21, and E2F-1 were upregulated, cdk2 and cyclin B were downregulated by PEA treatment, suggesting that PEA caused cell cycle arrest at the G2/M checkpoint. Therefore, these results indicate that PEA reduced the chemoresistance through inhibition of HSP70 expression and also induced apoptosis in chemoresistant YD-9 cells.
AbstractList Oral squamous carcinoma (OSCC) cells exhibit resistance to chemotherapeutic agent-mediated apoptosis in the late stage of malignancy. Increased levels of heat shock proteins 70 (HSP70) in cancer cells are known to confer resistance to apoptosis. Since recent advances in the understanding of bacterial toxins have produced new strategies for the treatment of cancers, we investigated the effect of Pseudomonas aeruginosa exotoxin A (PEA) on HSP70 expression and induction of apoptosis in chemoresistant OSCC cell line (YD-9). The apoptotic effect of PEA on chemoresistant YD-9 cells was confirmed by MTT, Hoechst and TUNEL stains, DNA electrophoresis, and Western blot analysis. While YD-9 cells showed high resistance to chemotherapeutic agents such as etoposide and 5-fluorouraci (5-FU), HSP70 antisense oligonucelotides sensitized chemoresistant YD-9 cells to etoposide and 5-FU. On the other hand, PEA significantly decreased the viability of YD-9 cells by deteriorating the HSP70-relating protecting system through inhibition of HSP70 expression and inducing apoptosis in YD-9 cells. Apoptotic manifestations were evidenced by changes in nuclear morphology, generation of DNA fragmentation, and activation of caspases. While p53, p21, and E2F-1 were upregulated, cdk2 and cyclin B were downregulated by PEA treatment, suggesting that PEA caused cell cycle arrest at the G2/M checkpoint. Therefore, these results indicate that PEA reduced the chemoresistance through inhibition of HSP70 expression and also induced apoptosis in chemoresistant YD-9 cells.
Purpose: Oral squamous carcinoma (OSCC) cells exhibit resistance to chemotherapeutic agent-mediated apoptosis in the late stage of malignancy. Increased levels of heat shock proteins 70 (HSP70) in cancer cells are known to confer resistance to apoptosis. Since recent advances in the understanding of bacterial toxins have produced new strategies for the treatment of cancers, we investigated the effect of Pseudomonas aeruginosa exotoxin A (PEA) on HSP70 expression and induction of apoptosis in chemoresistant OSCC cell line (YD-9). Materials and Methods:The apoptotic effect of PEA on chemoresistant YD-9 cells was confirmed by MTT,Hoechst and TUNEL stains, DNA electrophoresis, and Western blot analysis. Results: While YD-9 cells showed high resistance to chemotherapeutic agents such as etoposide and 5-fluorouraci (5-FU), HSP70 antisense oligonucelotides sensitized chemoresistant YD-9 cells to etoposide and 5-FU. On the other hand, PEA significantly decreased the viability of YD-9 cells by deteriorating the HSP70-relating protecting system through inhibition of HSP70 expression and inducing apoptosis in YD-9 cells. Apoptotic manifestations were evidenced by changes in nuclear morphology, generation of DNA fragmentation, and activation of caspases. While p53, p21, and E2F-1 were upregulated, cdk2 and cyclin B were downregulated by PEA treatment, suggesting that PEA caused cell cycle arrest at the G2/M checkpoint. Conclusion: Therefore, these results indicate that PEA reduced the chemoresistance through inhibition of HSP70 expression and also induced apoptosis in chemoresistant YD-9 cells. KCI Citation Count: 4
Oral squamous carcinoma (OSCC) cells exhibit resistance to chemotherapeutic agent-mediated apoptosis in the late stage of malignancy. Increased levels of heat shock proteins 70 (HSP70) in cancer cells are known to confer resistance to apoptosis. Since recent advances in the understanding of bacterial toxins have produced new strategies for the treatment of cancers, we investigated the effect of Pseudomonas aeruginosa exotoxin A (PEA) on HSP70 expression and induction of apoptosis in chemoresistant OSCC cell line (YD-9).PURPOSEOral squamous carcinoma (OSCC) cells exhibit resistance to chemotherapeutic agent-mediated apoptosis in the late stage of malignancy. Increased levels of heat shock proteins 70 (HSP70) in cancer cells are known to confer resistance to apoptosis. Since recent advances in the understanding of bacterial toxins have produced new strategies for the treatment of cancers, we investigated the effect of Pseudomonas aeruginosa exotoxin A (PEA) on HSP70 expression and induction of apoptosis in chemoresistant OSCC cell line (YD-9).The apoptotic effect of PEA on chemoresistant YD-9 cells was confirmed by MTT, Hoechst and TUNEL stains, DNA electrophoresis, and Western blot analysis.MATERIALS AND METHODSThe apoptotic effect of PEA on chemoresistant YD-9 cells was confirmed by MTT, Hoechst and TUNEL stains, DNA electrophoresis, and Western blot analysis.While YD-9 cells showed high resistance to chemotherapeutic agents such as etoposide and 5-fluorouraci (5-FU), HSP70 antisense oligonucelotides sensitized chemoresistant YD-9 cells to etoposide and 5-FU. On the other hand, PEA significantly decreased the viability of YD-9 cells by deteriorating the HSP70-relating protecting system through inhibition of HSP70 expression and inducing apoptosis in YD-9 cells. Apoptotic manifestations were evidenced by changes in nuclear morphology, generation of DNA fragmentation, and activation of caspases. While p53, p21, and E2F-1 were upregulated, cdk2 and cyclin B were downregulated by PEA treatment, suggesting that PEA caused cell cycle arrest at the G2/M checkpoint.RESULTSWhile YD-9 cells showed high resistance to chemotherapeutic agents such as etoposide and 5-fluorouraci (5-FU), HSP70 antisense oligonucelotides sensitized chemoresistant YD-9 cells to etoposide and 5-FU. On the other hand, PEA significantly decreased the viability of YD-9 cells by deteriorating the HSP70-relating protecting system through inhibition of HSP70 expression and inducing apoptosis in YD-9 cells. Apoptotic manifestations were evidenced by changes in nuclear morphology, generation of DNA fragmentation, and activation of caspases. While p53, p21, and E2F-1 were upregulated, cdk2 and cyclin B were downregulated by PEA treatment, suggesting that PEA caused cell cycle arrest at the G2/M checkpoint.Therefore, these results indicate that PEA reduced the chemoresistance through inhibition of HSP70 expression and also induced apoptosis in chemoresistant YD-9 cells.CONCLUSIONTherefore, these results indicate that PEA reduced the chemoresistance through inhibition of HSP70 expression and also induced apoptosis in chemoresistant YD-9 cells.
Author Park, Sang Rye
Park, Bong Soo
Oh, Kyu Seon
Gil, Young Gi
Kim, Gyoo Cheon
Lee, Kyoung Duk
Kim, Uk Kyu
AuthorAffiliation 1 Department of Oral Anatomy, School of Dentistry, Research Institute for Oral Biotechnology, Pusan National University, Yangsan, Korea
3 Department of Oral and Maxillofacial Surgery, School of Dentistry, Research Institute for Oral Biotechnology, Pusan National University, Yangsan, Korea
2 Department of Anatomy, College of Medicine, Kosin University, Busan, Korea
4 Basic Research Laboratory, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
AuthorAffiliation_xml – name: 3 Department of Oral and Maxillofacial Surgery, School of Dentistry, Research Institute for Oral Biotechnology, Pusan National University, Yangsan, Korea
– name: 1 Department of Oral Anatomy, School of Dentistry, Research Institute for Oral Biotechnology, Pusan National University, Yangsan, Korea
– name: 4 Basic Research Laboratory, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
– name: 2 Department of Anatomy, College of Medicine, Kosin University, Busan, Korea
Author_xml – sequence: 1
  givenname: Sang Rye
  surname: Park
  fullname: Park, Sang Rye
  organization: Department of Oral Anatomy, School of Dentistry, Research Institute for Oral Biotechnology, Pusan National University, Yangsan, Korea
– sequence: 2
  givenname: Kyoung Duk
  surname: Lee
  fullname: Lee, Kyoung Duk
  organization: Department of Oral Anatomy, School of Dentistry, Research Institute for Oral Biotechnology, Pusan National University, Yangsan, Korea
– sequence: 3
  givenname: Uk Kyu
  surname: Kim
  fullname: Kim, Uk Kyu
  organization: Department of Oral and Maxillofacial Surgery, School of Dentistry, Research Institute for Oral Biotechnology, Pusan National University, Yangsan, Korea
– sequence: 4
  givenname: Young Gi
  surname: Gil
  fullname: Gil, Young Gi
  organization: Department of Anatomy, College of Medicine, Kosin University, Busan, Korea
– sequence: 5
  givenname: Kyu Seon
  surname: Oh
  fullname: Oh, Kyu Seon
  organization: Basic Research Laboratory, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
– sequence: 6
  givenname: Bong Soo
  surname: Park
  fullname: Park, Bong Soo
  organization: Department of Oral Anatomy, School of Dentistry, Research Institute for Oral Biotechnology, Pusan National University, Yangsan, Korea
– sequence: 7
  givenname: Gyoo Cheon
  surname: Kim
  fullname: Kim, Gyoo Cheon
  organization: Department of Oral Anatomy, School of Dentistry, Research Institute for Oral Biotechnology, Pusan National University, Yangsan, Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/20635445$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001470608$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp9ks1OGzEUha2KqgTaB-im8q50kfT6bzyzqRRFlERCIiJ0bTkeDzGZscGeQfAKPDUOoajtoqsry9851773HKEDH7xF6DOBCWO8-v7Y3Uwo5JMgEzGRUL5DI1LJYkw5kwdoBIKwsZBVcYiOUroBoJIA_YAOKRRMcC5G6GmZ7FCHLnidsLZxuHY-JI1PH0IfHpzHU3xp68HYhGcb24Vok0u99sbi0OCLqFu8uht0F4YM6GiyutN4ZtsW3zuNF37j1q53we_wudU9Xm2C2eJlDL11PmEJ-GS-Wkr49hG9b3Sb7KfXeox-_Ty9ms3H5xdni9n0fGxYWfZjXZeSMFrYuuGScbCwJhQ4CM5owy2TlJcGOK9pkW8qwgGgoZARClUeDDtGJ3tfHxu1NU4F7V7qdVDbqKaXVwvFGCmrMqM_9ujtsO5sbazv84_VbXSdjo8vwr9vvNtkm3tFKyhLAdng66tBDHeDTb3qXDJ5OtrbPDIlGavKQpAqk1_-bPXW4_eqMkD2gIkhpWibN4SA2sVB5TioXRyUIEqoHIeskf9ojOv1bh35ta79j_IZ7dK5ig
CitedBy_id crossref_primary_10_3892_ijo_2013_1772
crossref_primary_10_1128_iai_00437_22
crossref_primary_10_1371_journal_pone_0091947
crossref_primary_10_3892_or_2013_2372
crossref_primary_10_3346_jkms_2025_40_e30
crossref_primary_10_3390_ijms14024185
crossref_primary_10_1080_21688370_2018_1479568
Cites_doi 10.1111/j.1582-4934.2008.00575.x
10.4049/jimmunol.161.10.5745
10.1124/jpet.109.155549
10.1073/pnas.0538044100
10.1007/s00384-007-0307-x
10.4161/cc.5.22.3448
10.1126/science.1117105
10.1517/13543780902752463
10.1016/S0962-8924(00)01874-2
10.1038/sj.onc.1208495
10.1093/carcin/bgi025
10.1073/pnas.0408229102
10.1007/s10059-009-0126-8
10.1016/j.toxicon.2003.08.003
10.1002/hed.20319
10.1101/gad.813200
10.1007/s00262-002-0353-8
10.1038/emm.2005.48
10.1038/ncb868
10.1016/S1368-8375(99)00079-2
10.1042/bst0290696
10.1016/j.molimm.2007.08.013
10.1158/0008-5472.CAN-08-2725
10.1084/jem.191.6.1005
10.1080/09553000802662595
10.1016/j.aodf.2007.10.014
10.1208/aapsj080363
10.1016/j.ejphar.2007.07.039
10.1007/s00726-007-0536-x
10.1002/ijc.20371
10.1111/j.1538-7836.2005.01110.x
10.1182/blood-2003-04-1317
10.1073/pnas.052707699
10.1074/jbc.M405594200
10.1074/jbc.M906383199
10.1016/j.pharmthera.2003.11.004
10.1016/j.dnarep.2004.03.034
10.1074/jbc.M200805200
10.1128/IAI.73.8.5115-5126.2005
10.1016/j.oraloncology.2003.09.012
ContentType Journal Article
Copyright Copyright: Yonsei University College of Medicine 2010 2010
Copyright_xml – notice: Copyright: Yonsei University College of Medicine 2010 2010
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ACYCR
DOI 10.3349/ymj.2010.51.5.708
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1976-2437
EndPage 716
ExternalDocumentID oai_kci_go_kr_ARTI_331898
PMC2908850
20635445
10_3349_ymj_2010_51_5_708
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.55
.GJ
123
29R
2WC
36B
5-W
53G
5RE
8JR
8XY
9ZL
AAYXX
ACYCR
ADBBV
ADRAZ
AEGXH
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
CS3
DIK
DU5
E3Z
EBD
EF.
EMB
EMOBN
F5P
GROUPED_DOAJ
GX1
HYE
KQ8
L7B
M48
MK0
O5R
O5S
OK1
OVT
P2P
PGMZT
RNS
RPM
SV3
TR2
X7M
XSB
ZGI
ZXP
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
M~E
ID FETCH-LOGICAL-c388t-ad871326edf47340e0b120405432f4e37248c044d260b1914000f202042092433
IEDL.DBID M48
ISSN 0513-5796
1976-2437
IngestDate Tue Nov 21 21:08:30 EST 2023
Thu Aug 21 14:29:33 EDT 2025
Fri Jul 11 05:18:27 EDT 2025
Mon Jul 21 05:52:31 EDT 2025
Thu Apr 24 23:03:45 EDT 2025
Tue Jul 01 04:02:08 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c388t-ad871326edf47340e0b120405432f4e37248c044d260b1914000f202042092433
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
G704-000409.2010.51.5.005
http://kmbase.medric.or.kr/Main.aspx?d=KMBASE&m=VIEW&i=0311120100510050708
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3349/ymj.2010.51.5.708
PMID 20635445
PQID 733986519
PQPubID 23479
PageCount 9
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_331898
pubmedcentral_primary_oai_pubmedcentral_nih_gov_2908850
proquest_miscellaneous_733986519
pubmed_primary_20635445
crossref_primary_10_3349_ymj_2010_51_5_708
crossref_citationtrail_10_3349_ymj_2010_51_5_708
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2010-09-01
PublicationDateYYYYMMDD 2010-09-01
PublicationDate_xml – month: 09
  year: 2010
  text: 2010-09-01
  day: 01
PublicationDecade 2010
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Yonsei medical journal
PublicationTitleAlternate Yonsei Med J
PublicationYear 2010
Publisher Yonsei University College of Medicine
연세대학교의과대학
Publisher_xml – name: Yonsei University College of Medicine
– name: 연세대학교의과대학
References Rashmi (10.3349/ymj.2010.51.5.708_ref6) 2005; 26
Stevens (10.3349/ymj.2010.51.5.708_ref43) 2004; 3
Pastan (10.3349/ymj.2010.51.5.708_ref14) 2003; 52
D'Silva (10.3349/ymj.2010.51.5.708_ref1) 2007; 100
Decker (10.3349/ymj.2010.51.5.708_ref22) 2004; 103
Hsu (10.3349/ymj.2010.51.5.708_ref26) 2004; 40
Endo-Munoz (10.3349/ymj.2010.51.5.708_ref39) 2009; 69
10.3349/ymj.2010.51.5.708_ref33
Thant (10.3349/ymj.2010.51.5.708_ref36) 2008; 28
Tong (10.3349/ymj.2010.51.5.708_ref3) 2000; 36
Li (10.3349/ymj.2010.51.5.708_ref9) 2009; 13
Grivicich (10.3349/ymj.2010.51.5.708_ref10) 2007; 22
Lee (10.3349/ymj.2010.51.5.708_ref16) 2005; 73
Spierings (10.3349/ymj.2010.51.5.708_ref4) 2005; 310
Harbour (10.3349/ymj.2010.51.5.708_ref38) 2000; 14
Sreedhar (10.3349/ymj.2010.51.5.708_ref7) 2004; 101
Azuma (10.3349/ymj.2010.51.5.708_ref25) 2004; 24
Li (10.3349/ymj.2010.51.5.708_ref29) 2000; 275
Nahle (10.3349/ymj.2010.51.5.708_ref40) 2002; 4
Furukawa (10.3349/ymj.2010.51.5.708_ref42) 2002; 277
Garrido (10.3349/ymj.2010.51.5.708_ref8) 2006; 5
(10.3349/ymj.2010.51.5.708_ref18) 2008; 42
Jenkins (10.3349/ymj.2010.51.5.708_ref28) 2004; 279
Andersson (10.3349/ymj.2010.51.5.708_ref21) 2004; 112
Meyn (10.3349/ymj.2010.51.5.708_ref31) 2009; 85
Oancea (10.3349/ymj.2010.51.5.708_ref35) 2006; 129
Bickels (10.3349/ymj.2010.51.5.708_ref11) 2002; 4
Cho (10.3349/ymj.2010.51.5.708_ref17) 2003; 42
Crowe (10.3349/ymj.2010.51.5.708_ref2) 2006; 28
Schümann (10.3349/ymj.2010.51.5.708_ref27) 1998; 161
Ismail (10.3349/ymj.2010.51.5.708_ref45) 2007; 575
Moretto (10.3349/ymj.2010.51.5.708_ref32) 2009; 18
Kreitman (10.3349/ymj.2010.51.5.708_ref20) 2006; 8
Lee (10.3349/ymj.2010.51.5.708_ref23) 2005; 37
Beere (10.3349/ymj.2010.51.5.708_ref5) 2001; 11
Koo (10.3349/ymj.2010.51.5.708_ref15) 2002; 99
Zhang (10.3349/ymj.2010.51.5.708_ref24) 2008; 45
Halaban (10.3349/ymj.2010.51.5.708_ref41) 2000; 191
Li (10.3349/ymj.2010.51.5.708_ref44) 2003; 100
Alley (10.3349/ymj.2010.51.5.708_ref13) 2009; 330
Gabai (10.3349/ymj.2010.51.5.708_ref30) 2005; 24
Marra (10.3349/ymj.2010.51.5.708_ref19) 2007; 33
Zacharski (10.3349/ymj.2010.51.5.708_ref12) 2005; 3
Wong (10.3349/ymj.2010.51.5.708_ref37) 2004; 101
Creagh (10.3349/ymj.2010.51.5.708_ref34) 2001; 29
References_xml – volume: 13
  start-page: 4540
  year: 2009
  ident: 10.3349/ymj.2010.51.5.708_ref9
  publication-title: J Cell Mol Med
  doi: 10.1111/j.1582-4934.2008.00575.x
– volume: 24
  start-page: 1449
  year: 2004
  ident: 10.3349/ymj.2010.51.5.708_ref25
  publication-title: Int J Oncol
– volume: 161
  start-page: 5745
  year: 1998
  ident: 10.3349/ymj.2010.51.5.708_ref27
  publication-title: J Immunol
  doi: 10.4049/jimmunol.161.10.5745
– volume: 330
  start-page: 932
  year: 2009
  ident: 10.3349/ymj.2010.51.5.708_ref13
  publication-title: J Pharmacol Exp Ther
  doi: 10.1124/jpet.109.155549
– volume: 100
  start-page: 2674
  year: 2003
  ident: 10.3349/ymj.2010.51.5.708_ref44
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0538044100
– volume: 22
  start-page: 1201
  year: 2007
  ident: 10.3349/ymj.2010.51.5.708_ref10
  publication-title: Int J Colorectal Dis
  doi: 10.1007/s00384-007-0307-x
– volume: 5
  start-page: 2592
  year: 2006
  ident: 10.3349/ymj.2010.51.5.708_ref8
  publication-title: Cell Cycle
  doi: 10.4161/cc.5.22.3448
– volume: 310
  start-page: 66
  year: 2005
  ident: 10.3349/ymj.2010.51.5.708_ref4
  publication-title: Science
  doi: 10.1126/science.1117105
– volume: 18
  start-page: 311
  year: 2009
  ident: 10.3349/ymj.2010.51.5.708_ref32
  publication-title: Expert Opin Investig Drugs
  doi: 10.1517/13543780902752463
– volume: 11
  start-page: 6
  year: 2001
  ident: 10.3349/ymj.2010.51.5.708_ref5
  publication-title: Trends Cell Biol
  doi: 10.1016/S0962-8924(00)01874-2
– volume: 4
  start-page: 471
  year: 2002
  ident: 10.3349/ymj.2010.51.5.708_ref11
  publication-title: Isr Med Assoc J
– volume: 24
  start-page: 3328
  year: 2005
  ident: 10.3349/ymj.2010.51.5.708_ref30
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1208495
– volume: 26
  start-page: 713
  year: 2005
  ident: 10.3349/ymj.2010.51.5.708_ref6
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgi025
– volume: 101
  start-page: 17783
  year: 2004
  ident: 10.3349/ymj.2010.51.5.708_ref37
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0408229102
– ident: 10.3349/ymj.2010.51.5.708_ref33
  doi: 10.1007/s10059-009-0126-8
– volume: 28
  start-page: 3579
  year: 2008
  ident: 10.3349/ymj.2010.51.5.708_ref36
  publication-title: Anticancer Res
– volume: 42
  start-page: 601
  year: 2003
  ident: 10.3349/ymj.2010.51.5.708_ref17
  publication-title: Toxicon
  doi: 10.1016/j.toxicon.2003.08.003
– volume: 28
  start-page: 15
  year: 2006
  ident: 10.3349/ymj.2010.51.5.708_ref2
  publication-title: Head Neck
  doi: 10.1002/hed.20319
– volume: 14
  start-page: 2393
  year: 2000
  ident: 10.3349/ymj.2010.51.5.708_ref38
  publication-title: Genes Dev
  doi: 10.1101/gad.813200
– volume: 52
  start-page: 338
  year: 2003
  ident: 10.3349/ymj.2010.51.5.708_ref14
  publication-title: Cancer Immunol Immunother
  doi: 10.1007/s00262-002-0353-8
– volume: 37
  start-page: 379
  year: 2005
  ident: 10.3349/ymj.2010.51.5.708_ref23
  publication-title: Exp Mol Med
  doi: 10.1038/emm.2005.48
– volume: 4
  start-page: 859
  year: 2002
  ident: 10.3349/ymj.2010.51.5.708_ref40
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb868
– volume: 129
  start-page: 279
  year: 2006
  ident: 10.3349/ymj.2010.51.5.708_ref35
  publication-title: Methods Mol Med
– volume: 36
  start-page: 236
  year: 2000
  ident: 10.3349/ymj.2010.51.5.708_ref3
  publication-title: Oral Oncol
  doi: 10.1016/S1368-8375(99)00079-2
– volume: 29
  start-page: 696
  year: 2001
  ident: 10.3349/ymj.2010.51.5.708_ref34
  publication-title: Biochem Soc Trans
  doi: 10.1042/bst0290696
– volume: 45
  start-page: 1470
  year: 2008
  ident: 10.3349/ymj.2010.51.5.708_ref24
  publication-title: Mol Immunol
  doi: 10.1016/j.molimm.2007.08.013
– volume: 69
  start-page: 1800
  year: 2009
  ident: 10.3349/ymj.2010.51.5.708_ref39
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-08-2725
– volume: 191
  start-page: 1005
  year: 2000
  ident: 10.3349/ymj.2010.51.5.708_ref41
  publication-title: J Exp Med
  doi: 10.1084/jem.191.6.1005
– volume: 85
  start-page: 107
  year: 2009
  ident: 10.3349/ymj.2010.51.5.708_ref31
  publication-title: Int J Radiat Biol
  doi: 10.1080/09553000802662595
– volume: 100
  start-page: 182
  year: 2007
  ident: 10.3349/ymj.2010.51.5.708_ref1
  publication-title: Alpha Omegan
  doi: 10.1016/j.aodf.2007.10.014
– volume: 8
  start-page: E532
  year: 2006
  ident: 10.3349/ymj.2010.51.5.708_ref20
  publication-title: AAPS J
  doi: 10.1208/aapsj080363
– volume: 575
  start-page: 12
  year: 2007
  ident: 10.3349/ymj.2010.51.5.708_ref45
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2007.07.039
– volume: 42
  start-page: 197
  year: 2008
  ident: 10.3349/ymj.2010.51.5.708_ref18
  publication-title: Mikrobiyol Bul
– volume: 33
  start-page: 273
  year: 2007
  ident: 10.3349/ymj.2010.51.5.708_ref19
  publication-title: Amino Acids
  doi: 10.1007/s00726-007-0536-x
– volume: 112
  start-page: 475
  year: 2004
  ident: 10.3349/ymj.2010.51.5.708_ref21
  publication-title: Int J Cancer
  doi: 10.1002/ijc.20371
– volume: 3
  start-page: 424
  year: 2005
  ident: 10.3349/ymj.2010.51.5.708_ref12
  publication-title: J Thromb Haemost
  doi: 10.1111/j.1538-7836.2005.01110.x
– volume: 103
  start-page: 2718
  year: 2004
  ident: 10.3349/ymj.2010.51.5.708_ref22
  publication-title: Blood
  doi: 10.1182/blood-2003-04-1317
– volume: 99
  start-page: 3052
  year: 2002
  ident: 10.3349/ymj.2010.51.5.708_ref15
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.052707699
– volume: 279
  start-page: 37201
  year: 2004
  ident: 10.3349/ymj.2010.51.5.708_ref28
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M405594200
– volume: 275
  start-page: 25665
  year: 2000
  ident: 10.3349/ymj.2010.51.5.708_ref29
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M906383199
– volume: 101
  start-page: 227
  year: 2004
  ident: 10.3349/ymj.2010.51.5.708_ref7
  publication-title: Pharmacol Ther
  doi: 10.1016/j.pharmthera.2003.11.004
– volume: 3
  start-page: 1071
  year: 2004
  ident: 10.3349/ymj.2010.51.5.708_ref43
  publication-title: DNA Repair (Amst)
  doi: 10.1016/j.dnarep.2004.03.034
– volume: 277
  start-page: 39760
  year: 2002
  ident: 10.3349/ymj.2010.51.5.708_ref42
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M200805200
– volume: 73
  start-page: 5115
  year: 2005
  ident: 10.3349/ymj.2010.51.5.708_ref16
  publication-title: Infect Immun
  doi: 10.1128/IAI.73.8.5115-5126.2005
– volume: 40
  start-page: 461
  year: 2004
  ident: 10.3349/ymj.2010.51.5.708_ref26
  publication-title: Oral Oncol
  doi: 10.1016/j.oraloncology.2003.09.012
SSID ssj0027102
Score 1.9017687
Snippet Oral squamous carcinoma (OSCC) cells exhibit resistance to chemotherapeutic agent-mediated apoptosis in the late stage of malignancy. Increased levels of heat...
Purpose: Oral squamous carcinoma (OSCC) cells exhibit resistance to chemotherapeutic agent-mediated apoptosis in the late stage of malignancy. Increased levels...
SourceID nrf
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 708
SubjectTerms ADP Ribose Transferases - pharmacology
Antineoplastic Agents - pharmacology
Apoptosis - drug effects
Bacterial Toxins - pharmacology
Blotting, Western
Carcinoma, Squamous Cell - drug therapy
Carcinoma, Squamous Cell - metabolism
Cell Cycle - drug effects
Cell Line, Tumor
Chromatography, Liquid
Cyclin B - metabolism
Cyclin-Dependent Kinase 2 - metabolism
Drug Resistance, Neoplasm - drug effects
E2F1 Transcription Factor - metabolism
Electrophoresis
Exotoxins - pharmacology
HSP70 Heat-Shock Proteins - genetics
HSP70 Heat-Shock Proteins - metabolism
Humans
In Situ Nick-End Labeling
Mouth Neoplasms - drug therapy
Mouth Neoplasms - metabolism
Original
Pseudomonas aeruginosa Exotoxin A
Tandem Mass Spectrometry
Tumor Suppressor Protein p53 - metabolism
Virulence Factors - pharmacology
의학일반
Title Pseudomonas aeruginosa Exotoxin A Reduces Chemoresistance of Oral Squamous Carcinoma Cell via Inhibition of Heat Shock Proteins 70 (HSP70)
URI https://www.ncbi.nlm.nih.gov/pubmed/20635445
https://www.proquest.com/docview/733986519
https://pubmed.ncbi.nlm.nih.gov/PMC2908850
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001470608
Volume 51
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Yonsei Medical Journal, 2010, 51(5), , pp.708-716
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELe2ISFeJr7pxioj8QBIKYk_8vGApqna1CEVKkrF3iwncdawztmSFnX_An81d0laKKoQT4mUcxz5zvb94rvfEfJaw5aTCmEczY10RMhiuNOhk6QRizkzkhvMdx5-8gcT8fFCXuyQVXmrdgCrrdAO60lNyllveXt3DBP-AyJOLqL3d9ffmxgt6fVkL8DU33uwMfmIxYYi_I2_vDoEEcyQO5iC2Rxybn_Fxja1a8tsmwf6dyDlHzvT2UOy37qU9KSxgUdkx9jH5P6wPTR_Qn6OKrNIC7A3XVFtysVlbotK09NlMS-WuaUn9AsSuJqKIn1AAQAcnUqwBlpk9DP0SMe3C43_CGgfSw_Z4lrTvpnN6I9c03M7zeM68AvFB7C20_EUVlk6QgqI3FY0cOmbwXgUuG-fksnZ6df-wGlLMDgJD8O5o1MAVODhmTQTAReucWOPwbyXgrNMGB4wESauECnAohip4mCFzRgm3DIXkB3nz8ieLax5QSgTiWGpYEZDy0REOmaBlMxPQz-Jue93iLsacZW0_ORYJmOmAKegkhQoSaGSlPSUVKCkDnm3bnLTkHP8S_gVqFFdJblCSm28XhbqqlQAHM6hjRdGIENXSlYwzfDsRFsDw6sCzqPQB3e3Q543Ol_3yMDLQ0qjDgk2rGEtgN1tPrH5tGbyZhhlJt2D__i0Q_KgCVzA8LaXZG9eLswR-EPzuEt2pfOtW_9N6NYW_wuBsAgc
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pseudomonas+aeruginosa+Exotoxin+A+Reduces+Chemoresistance+of+Oral+Squamous+Carcinoma+Cell+via+Inhibition+of+Heat+Shock+Proteins+70+%28HSP70%29&rft.jtitle=Yonsei+medical+journal&rft.au=%EB%B0%95%EC%83%81%EB%A1%80&rft.au=%EC%9D%B4%EA%B2%BD%EB%8D%95&rft.au=%EA%B9%80%EC%9A%B1%EA%B7%9C&rft.au=%EA%B8%B8%EC%98%81%EA%B8%B0&rft.date=2010-09-01&rft.pub=%EC%97%B0%EC%84%B8%EB%8C%80%ED%95%99%EA%B5%90%EC%9D%98%EA%B3%BC%EB%8C%80%ED%95%99&rft.issn=0513-5796&rft.eissn=1976-2437&rft.spage=708&rft.epage=716&rft_id=info:doi/10.3349%2Fymj.2010.51.5.708&rft.externalDBID=n%2Fa&rft.externalDocID=oai_kci_go_kr_ARTI_331898
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0513-5796&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0513-5796&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0513-5796&client=summon